Amorfix Life Sciences Ltd. (AMF) - Product Pipeline Analysis - New Market Report Now Available
Amorfix Life Sciences Ltd. (Amorfix) is a theranostics company engaged in developing therapeutic products and diagnostic devices for treatment of brain-wasting diseases such as Amyotrophic Lateral Sclerosis (ALS), Alzheimer’s disease, Parkinson’s disease and variant Creutzfeldt - Jakob disease (vCJD). The company intends to develop diagnostic kits, biologic therapeutics, drug therapeutics, and prophylactics, such as vaccines for the treatment of aggregated misfolded proteins (AMP). It’s lead programs include a diagnostic blood screening test for vCJD and a therapy for ALS. Amorfix...
View full press release